Dawn M. Riddle

3.7k total citations · 2 hit papers
18 papers, 2.7k citations indexed

About

Dawn M. Riddle is a scholar working on Neurology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Dawn M. Riddle has authored 18 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Neurology, 12 papers in Physiology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Dawn M. Riddle's work include Parkinson's Disease Mechanisms and Treatments (12 papers), Alzheimer's disease research and treatments (11 papers) and Neurological disorders and treatments (6 papers). Dawn M. Riddle is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (12 papers), Alzheimer's disease research and treatments (11 papers) and Neurological disorders and treatments (6 papers). Dawn M. Riddle collaborates with scholars based in United States. Dawn M. Riddle's co-authors include Virginia M.‐Y. Lee, Anna Stieber, John Q. Trojanowski, Laura A. Volpicelli‐Daley, Kelvin C. Luk, Tapan P. Patel, David F. Meaney, Bin Zhang, John Q. Trojanowski and Dustin J. Covell and has published in prestigious journals such as Cell, Neuron and The Journal of Experimental Medicine.

In The Last Decade

Dawn M. Riddle

18 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death

2011 1.2k citations Laura A. Volpicelli‐Daley, Kelvin C. Luk et al. Neuron profile →
Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons

2013 547 citations Jing Guo, Dustin J. Covell et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dawn M. Riddle United States	18	1.9k	1.4k	820	716	661	18	2.7k
Masami Masuda‐Suzukake Japan	26	2.1k 1.1×	1.3k 1.0×	752 0.9×	1.1k 1.6×	755 1.1×	39	3.1k
Victoria Kehm United States	7	2.4k 1.3×	1.2k 0.9×	1.0k 1.3×	823 1.1×	735 1.1×	7	3.0k
Abid Oueslati Canada	21	2.6k 1.3×	1.3k 0.9×	1.3k 1.6×	1.1k 1.5×	506 0.8×	39	3.6k
John Q. Trojanowski United States	18	1.8k 0.9×	1.2k 0.9×	858 1.0×	858 1.2×	648 1.0×	26	2.9k
Evangelia Emmanouilidou Greece	18	1.5k 0.8×	801 0.6×	644 0.8×	909 1.3×	477 0.7×	32	2.4k
Raquel Ros Spain	9	2.1k 1.1×	887 0.7×	1.0k 1.3×	470 0.7×	451 0.7×	15	2.4k
Mario Ezquerra Spain	28	1.7k 0.9×	1.1k 0.8×	782 1.0×	1.3k 1.8×	542 0.8×	85	3.0k
Patrick O’Brien United States	5	2.7k 1.4×	1.4k 1.0×	1.1k 1.4×	964 1.3×	853 1.3×	6	3.5k
Patrizia Rizzu Netherlands	22	1.2k 0.6×	1.4k 1.0×	490 0.6×	1.0k 1.5×	519 0.8×	44	2.5k
Albert A. Davis United States	24	1.4k 0.7×	690 0.5×	1.1k 1.4×	1.3k 1.9×	461 0.7×	42	3.0k

Countries citing papers authored by Dawn M. Riddle

Since Specialization

Citations

This map shows the geographic impact of Dawn M. Riddle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn M. Riddle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn M. Riddle more than expected).

Fields of papers citing papers by Dawn M. Riddle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawn M. Riddle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn M. Riddle. The network helps show where Dawn M. Riddle may publish in the future.

Co-authorship network of co-authors of Dawn M. Riddle

This figure shows the co-authorship network connecting the top 25 collaborators of Dawn M. Riddle. A scholar is included among the top collaborators of Dawn M. Riddle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawn M. Riddle. Dawn M. Riddle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

McBride, Jennifer D., et al.. (2022). Inhibition of CK2 mitigates Alzheimer’s tau pathology by preventing NR2B synaptic mislocalization. Acta Neuropathologica Communications. 10(1). 30–30. 18 indexed citations

Xu, Hong, Garrett S. Gibbons, Lakshmi Changolkar, et al.. (2021). In vitro amplification of pathogenic tau conserves disease-specific bioactive characteristics. Acta Neuropathologica. 141(2). 193–215. 40 indexed citations

Gibbons, Garrett S., Soojung Kim, Qihui Wu, et al.. (2020). Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer’s disease. Molecular Neurodegeneration. 15(1). 64–64. 30 indexed citations

Wu, Qihui, Hajime Takano, Dawn M. Riddle, et al.. (2019). α-Synuclein (αSyn) Preformed Fibrils Induce Endogenous αSyn Aggregation, Compromise Synaptic Activity and Enhance Synapse Loss in Cultured Excitatory Hippocampal Neurons. Journal of Neuroscience. 39(26). 5080–5094. 78 indexed citations

Henderson, Michael X., Eli J. Cornblath, Chao Peng, et al.. (2019). Glucocerebrosidase Activity Modulates Neuronal Susceptibility to Pathological α-Synuclein Insult. Neuron. 105(5). 822–836.e7. 99 indexed citations

Henderson, Michael X., Dustin J. Covell, Charlotte Hiu-Yan Chung, et al.. (2019). Characterization of novel conformation-selective α-synuclein antibodies as potential immunotherapeutic agents for Parkinson's disease. Neurobiology of Disease. 136. 104712–104712. 32 indexed citations

Bassil, Fares, Hannah J. Brown, Chantal Maghames, et al.. (2019). Amyloid-Beta (Aβ) Plaques Promote Seeding and Spreading of Alpha-Synuclein and Tau in a Mouse Model of Lewy Body Disorders with Aβ Pathology. Neuron. 105(2). 260–275.e6. 160 indexed citations

Narasimhan, Sneha, Lakshmi Changolkar, Dawn M. Riddle, et al.. (2019). Human tau pathology transmits glial tau aggregates in the absence of neuronal tau. The Journal of Experimental Medicine. 217(2). 73 indexed citations

Luna, Esteban, Dawn M. Riddle, Anna Caputo, et al.. (2018). Differential α-synuclein expression contributes to selective vulnerability of hippocampal neuron subpopulations to fibril-induced toxicity. Acta Neuropathologica. 135(6). 855–875. 89 indexed citations

10.

Gibbons, Garrett S., Rachel A. Banks, Bumjin Kim, et al.. (2018). Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies. Journal of Neuropathology & Experimental Neurology. 77(3). 216–228. 61 indexed citations

11.

Henderson, Michael X., Charlotte Hiu-Yan Chung, Dawn M. Riddle, et al.. (2017). Unbiased Proteomics of Early Lewy Body Formation Model Implicates Active Microtubule Affinity-Regulating Kinases (MARKs) in Synucleinopathies. Journal of Neuroscience. 37(24). 5870–5884. 21 indexed citations

12.

Gibbons, Garrett S., Rachel A. Banks, Bumjin Kim, et al.. (2017). GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils. Journal of Neuroscience. 37(47). 11485–11494. 37 indexed citations

13.

Covell, Dustin J., John Robinson, Rizwan Akhtar, et al.. (2017). Novel conformation‐selective alpha‐synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease. Neuropathology and Applied Neurobiology. 43(7). 604–620. 53 indexed citations

14.

Volpicelli‐Daley, Laura A., et al.. (2014). Formation of α-synuclein Lewy neurite–like aggregates in axons impedes the transport of distinct endosomes. Molecular Biology of the Cell. 25(25). 4010–4023. 188 indexed citations

15.

Kwong, Linda K., David J. Irwin, Adam K. Walker, et al.. (2014). Novel monoclonal antibodies to normal and pathologically altered human TDP-43 proteins. Acta Neuropathologica Communications. 2(1). 33–33. 27 indexed citations

16.

Guo, Jing, Dustin J. Covell, Michiyo Iba, et al.. (2013). Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons. Cell. 154(1). 103–117. 547 indexed citations breakdown →

17.

Volpicelli‐Daley, Laura A., Kelvin C. Luk, Tapan P. Patel, et al.. (2011). Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death. Neuron. 72(1). 57–71. 1159 indexed citations breakdown →

18.

Li, Xinming, Émmanuelle Nicolas, Steven H. Seeholzer, et al.. (2011). APC+/− alters colonic fibroblast proteome in FAP. Oncotarget. 2(3). 197–208. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact